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Direct  visualization  of  myocardial  ﬁbrosis  in  vivo  remains  a  challenge.  In  hypertrophic
cardiomyopathy,  myocardial  ﬁbrosis  is  usually  imaged  by  late  gadolinium  enhancement
cardiac  magnetic  resonance  (LGE-CMR),  with  major  prognostic  implications.  Extensive
areas  of  collagen  within  the  myocardium  produce  abnormal  reﬂection  of  ultrasound.
The  ability  of  three-dimensional  contrast-enhanced  echocardiography  (3DCE)  to  detect
myocardial  scars  was  recently  emphasized  in  ischaemic  cardiomyopathy.  In  the  cases  of
three  patients  with  hypertrophic  cardiomyopathy,  harmonic  3DCE  was  performed  with  an
iE33  (Philips®)  equipped  with  a  matrix  array  transducer  (×4  2—4  MHz).  After  intravenous
injection  of  contrast  (SonoVue®,  bolus  of  0.5  mL),  pyramidal  full-volume  data  sets  from
the  apical  transducer  position  were  acquired  just  after  irruption  and  homogenous  distribu-
tion  of  contrast  in  the  left  ventricle,  with  a  high  mechanical  index  (0.4).  Compression
was  adjusted  to  soften  the  healthy  myocardium.  Gain  settings  were  optimized.  Com-
parison  of  3DCE  and  LGE-CMR  images  clearly  demonstrated  agreement.  For  patient  1,
3DCE  revealed  a  hyperechogen  nodule  in  the  mid  septum  (Fig.  1,  panel  1a).  Findings
with  LGE-CMR  correlated  with  3DCE,  with  the  visualization  of  a  nodular  area  of  hyper-
enhancement  in  the  mid  septum  (Fig.  1,  panels  1b  and  1c).  In  patient  2,  3DCE  showed
an  area  of  hyperechogenicity  for  basal  and  mid-septal  segments  (Fig.  1,  panel  2a).  LGE-
CMR  demonstrated  a  large  area  of  septal  hyperenhancement  (Fig.  1,  panels  2b  and  2c),
well  correlated  with  the  echocardiographic  ﬁndings.  For  patient  3,  3DCE  did  not  show  any
region  of  hyperechogenicity  (Fig.  1,  panel  3a).  In  the  same  way,  LGE-CMR  did  not  reveal
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